AHCC10
Find out about the ELEGANCE study, which tracks biomarkers in patients at high risk of liver cancer. Recruitment of 2,002 subjects has been completed, with follow-up and data analysis now under way.
Trial summary of AHCC 10
AHCC10 | Early Detection of Hepatocellular Carcinoma: miRNA, microbiome and imaging biomarkers in the evolution of chronic liver disease in a high-risk prospective cohort (ELEGANCE) (NCT04965259) |
Status | Completed recruitment of 2,002 subjects in Mar 2025. Follow-up and data analysis in progress. |
Contributing Principal | Singapore Eugene Wong Yu Jun (Changi General Hospital), Toh Han Chong (National Cancer Centre), Lee Guan Huei (National University Hospital), Jason Chang (Singapore General Hospital), Chong Oi Fong (SingHealth Polyclinics – Bedok), Sabrina Wee (SingHealth Polyclinics – Bukit Merah), Tan Kee Tung (SingHealth Polyclinics – Marine Parade), Ong Kok Kiong (SingHealth Polyclinics – Outram), Tan Ngiap Chuan (SingHealth Polyclinics – Pasir Ris), Yeap Xin Yi (SingHealth Polyclinics – Punggol), Choo Wei Song Jeremy (SingHealth Polyclinics – Sengkang), Sulaiha Binte Ithnin (SingHealth Polyclinics – Tampines), Marianne De Roza and Kalki Rajamanickam (Sengkang General Hospital), Yang Wei Lyn (Tan Tock Seng Hospital) |
Protocol Chair | Pierce Chow |